Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

NCT03468790 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
393
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Biomabs Pharmaceutical Co., Ltd.